ResMed (RMD) free cash flow was $1.6B in FY2026 (-1% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2026
$1.6B
-1%
2025
$1.7B
+28%
2024
$1.3B
+133%
2023
$559M
+187%
2022
$195M
-69%
2021
$620M
-11%
2020
$696M
+82%
2019
$382M
-12%
2018
$434M
+27%
2017
$343M
-29%
2016
$480M
+54%
2015
$311M
+0%
2014
$310M
-6%
2013
$331M
+1%
2012
$329M
+57%
2011
$210M
+66%
2010
$127M
+2%
2009
$125M
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$403M
Q1 2026
$520M
Q4 2025
$310M
Q3 2025
$412M
Q2 2025
$508M
Q1 2025
$558M
Q4 2024
$286M
Q3 2024
$306M
Q2 2024
$401M
Q1 2024
$379M
Q4 2023
$248M
Q3 2023
$245M
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.